Back to Lung Cancer
NCT03804554
NCT03804554
Who may be able to join
Who might be able to join this trial:
- You are 18 years of age or older
- You have been diagnosed with non-small cell lung cancer (a common type of lung cancer)
- You were treated with a medication called nivolumab through a specific Australian patient access program
- You started taking nivolumab between May 2015 and August 2017
- Your treating doctor is willing to share your medical data for this study
- The required ethical approvals at your local hospital or medical institution have been met
Who may not be able to join:
- There is not enough medical data available about you to be included in the study
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Trial details
Status
Completed
Phase
Not Applicable
Sponsor
Bristol-Myers Squibb
Registry
clinicaltrials_gov
Start date
3 October 2018
Est. completion
12 August 2021
Where this trial is recruiting
🇦🇺 Australia
1 site(s) in Australia. Confirm current status and contact details directly with the trial site.
Primary endpoints
Time to treatment failure (TTF)
Can't join this trial?
Data last synced from ClinicalTrials.gov: 30 June 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.